A Case Control Observational Study to Assess CYDAR Automated Overlay Guidance During EVAR (CYDAR-IRAAA)

NHS Foundation Trust

Status: Completed

Conditions: Aortic Aneurysm

Treatments: Device: CYDAR

Study type: Observational

Funder types: Other

Identifiers

NCT02592733

IRAS171317

Details and patient eligibility

About

This is an observational trial to determine if use of fusion imaging in infrarenal endovascular aneurysm repair will decrease the radiation dose and improve patient safety for this procedure.

Full description

The aorta is the main artery of the body. An aortic abdominal aneurysm (AAA) is defined as an abnormal dilatation of the aorta, based on a diameter of 3 cm or more, due to a weakness of the aortic wall that is prone to rupture, leading to a lifethreatening condition.

Once AAA diagnosed, a CTscan is required to assess the anatomy and if indicate an endovascular aneurysm repair (EVAR) is performed. This mini invasive procedure allows the exclusion of the AAA by positioning an endograft inside the aorta through a femoral access under live Xrays (fluoroscopy) guidance.

The Xrays are good at showing bones and radioopaque endovascular tools, but they do not show soft tissues like the aorta, and they produce flat (2D) images that superimpose all the 3D anatomical features. In order to see the aorta, physicians have to inject iodinated contrast during high quality imaging recording. One way to improve clinicians' perception of peroperative 3D vascular anatomy is to accurately overlay selected information from the preoperative CT scan (a 3D vascular mask) onto the live Xray image creating a '3D roadmap'. This advanced imaging application is currently available only in the latest expensive hybrid rooms. This trial will examine the clinical benefits of the first advanced imaging application allowing automated 3D overlay guidance during EVAR in any theatre. The software, combined with secure and certified cloud high performance computing, deduces the patient position from comparing the bony anatomy visible on the Xray to that on the patient's CT scan, enabling it to produce and update accurate and reliable overlays of the diagnostic CT 3D vascular mask throughout the operation (www.cydar.co.uk). Expected benefits include reducing the total Xray exposure of the patients and staff, reduced use of iodinated contrast (a major cause of kidney failure) and shortening procedure duration.

Enrollment: 44 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. willing and able to give informed consent,and
2. aged 18 or older, and
3. been scheduled for endovascular repair of an infrarenal aortic aneurysm (EVAR), and
4. who have had a preoperative diagnostic CT scan, and
5. able (in the investigator's opinion) and willing to comply with the study requirements.

Exclusion criteria

1. Female participants who is pregnant or planning pregnancy during the course of the study.
2. Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study.
3. Any patient requiring an associated procedure (iliac branch device implantation, renal or mesenteric angioplasty)
4. Ruptured AAA and emergency procedures

Trial design

44 participants in 2 patient groups

Historical Cohort

Description:

Patients who have undergone infrarenal endovascular repair at each centre in the past.

Prospective Cohort

Description:

Patients undergoing infrarenal endovascular repair in the study using CYDAR in addition to the local angiography equipment.

Treatment:

Device: CYDAR